Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Schaer, David A ^a   Li, Yongbiao ^a   Merghoub, Taha ^a   Rizzuto, Gabrielle A ^a,b   Shemesh, Amos ^a   Cohen, Adam D ^a,c   Li, Yanyun ^a   Avogadri, Francesca ^a   Toledo Crow, Ricardo ^a   Houghton, Alan N ^a,b   Wolchok, Jedd D ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; PROTEIN OT 1; PROTEIN PMEL 1; SELF ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; AUTOANTIGEN; EPITOPE;

ADOPTIVE TRANSFER; ADVANCED MULTIMODE CONFOCAL MICROSCOPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; LYMPHOCYTE PROLIFERATION; MELANOMA; MICROSCOPE; MOUSE; NONHUMAN; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION; TWO PHOTON MICROSCOPE; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EXPERIMENTAL MELANOMA; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; METHODOLOGY; PATHOLOGY; TIME; TUMOR ASSOCIATED LEUKOCYTE;

MUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIGENS; CELL COMMUNICATION; CELL PROLIFERATION; DISEASE PROGRESSION; EPITOPES; KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 79959444953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021214     Document Type: Article

References (29)

1. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD, (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998.
2. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, et al. (2004) Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 200: 771-782.
3. Dunn GP, Old LJ, Schreiber RD, (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148.
4. Smyth MJ, Dunn GP, Schreiber RD, (2006) Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90: 1-50.
5. Koneru M, Schaer D, Monu N, Ayala A, Frey AB, (2005) Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. J Immunol 174: 1830-1840.
6. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V, (2008) Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 222: 162-179.
7. Monu N, Frey AB, (2007) Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells. Cancer Res 67: 11447-11454.
8. Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, et al. (1997) Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med 186: 645-653.
9. Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, et al. (2008) Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science 319: 215-220.
10. Cahalan MD, Parker I, (2006) Imaging the choreography of lymphocyte trafficking and the immune response. Curr Opin Immunol 18: 476-482.
11. Germain RN, Miller MJ, Dustin ML, Nussenzweig MC, (2006) Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol 6: 497-507.
12. Breart B, Lemaitre F, Celli S, Bousso P, (2008) Two-photon imaging of intratumoral CD8 T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 118: 1390-1397.
13. Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S, (2007) In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 204: 345-356.
14. Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, et al. (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 203: 2749-2761.
15. Quezada SA, Peggs KS, Curran MA, Allison JP, (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J Clin Invest 116: 1935-1945.
16. Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, et al. (2001) A method that allows easy characterization of tumor-infiltrating lymphocytes. J Immunol Methods 253: 163-175.
17. Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, et al. (1998) gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med 188: 277-286.
18. Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, et al. (2009) Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. Journal of Experimental Medicine 206: 849-866.
19. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, et al. (2003) Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 198: 569-580.
20. Badovinac VP, Haring JS, Harty JT, (2007) Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 26: 827-841.
21. Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, et al. (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
22. Chen M-L, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, et al. (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proceedings of the National Academy of Sciences of the United States of America 102: 419-424.
23. Zipfel WR, Williams RM, Christie R, Nikitin AY, Hyman BT, et al. (2003) Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. Proc Natl Acad Sci U S A 100: 7075-7080.
24. Sitkovsky M, Lukashev D, (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5: 712-721.
25. Rodriguez PC, Ochoa AC, (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222: 180-191.
26. Germain RN, Bajenoff M, Castellino F, Chieppa M, Egen JG, et al. (2008) Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol Rev 221: 163-181.
27. Bajenoff M, Egen JG, Qi H, Huang AY, Castellino F, et al. (2007) Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 28: 346-352.
28. Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, et al. (2001) CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 167: 5042-5051.
29. Koneru M, Monu N, Schaer D, Barletta J, Frey AB, (2006) Defective Adhesion in Tumor Infiltrating CD8+ T Cells. J Immunol 176: 6103-6111.